BRAIN Biotech AG and Formo Bio GmbH are launching a strategic collaboration to further advance the production of animal-free milk proteins. As experts in their field, the two biotech companies are powering European innovation. Formo will scale up their bioidentical milk protein production with a genome editing technology, leveraging BRAIN Biotech's expertise and its proprietary BEC platform.

The strategic alliance aims to optimize the microorganisms to further expand novel and sustainable protein production for commercial use through precision fermentation. Formo is introducing an entirely novel product category alongside both animal-derived products and plant-based alternatives: The Berlin-based startup develops identical milk proteins with specialized microorganisms. As the first European company, Formo strives to revolutionize the $700 billion dairy market while cutting down on gigatons of CO2 emissions. Formo builds on the increasing demand for sustainable food among consumers: Recently, the company conducted a consumer survey confirming that 79% of consumers are willing to try animal-free cheese products.